Equity Analysis

Quarterly Results

    SMS Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    532815
    INE812G01025
    70.607746
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    SMSPHARMA
    34.81
    2042.23
    EPS(TTM)
    Face Value()
    Div & Yield %:
    6.93
    1
    0.17
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales196.75164.45245.80
Other Operating Income0.000.000.00
Other Income 1.301.371.65
Total Income198.05165.82247.44
Total Expenditure 164.89130.99212.31
PBIDT33.1734.8335.13
Interest 4.614.675.61
PBDT28.5630.1729.52
Depreciation8.628.387.92
Tax4.705.304.63
Fringe Benefit Tax0.000.000.00
Deferred Tax0.980.161.06
Reported Profit After Tax14.2616.3315.92
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item14.2616.3315.92
EPS (Unit Curr.)1.681.931.88
EPS (Adj) (Unit Curr.)1.681.931.88
Calculated EPS (Unit Curr.)1.681.931.88
Calculated EPS (Adj) (Unit Curr.)1.681.931.88
Calculated EPS (Ann.) (Unit Curr.)6.747.727.52
Calculated EPS (Adj) (Ann.) (Unit Curr.)6.747.727.52
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity8.478.478.47
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)16.8621.1814.29
PBDTM(%)14.5218.3512.01
PATM(%)7.259.936.48
Dividend Per Share(Rs)0.000.000.00
Diluted EPS1.681.931.88